List of works - Simon Dujardin

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

scientific article

Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.

scientific article published on January 2012

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons

scientific article published on 23 April 2021

Different tau species lead to heterogeneous tau pathology propagation and misfolding

scholarly article by Simon Dujardin et al published 29 November 2018 in Acta neuropathologica communications

Ectosomes: a new mechanism for non-exosomal secretion of tau protein

scientific article

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

scientific article published on 04 November 2019

Invited review: Animal models of tauopathies and their implications for research/translation into the clinic

scientific article

Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain

scientific article published on 23 April 2013

Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies

scientific article published on 30 January 2014

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds

scientific article published on 19 October 2020

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease

scientific article published on 01 January 2019

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease

scientific article published on 01 September 2018

Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo.

scientific article published on 17 December 2018

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease

scientific article published on 22 June 2020

Tau protein liquid-liquid phase separation can initiate tau aggregation

scientific article published on 22 February 2018

Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo

scientific article published on 01 July 2018

Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies

scientific article

What is the evidence that tau pathology spreads through prion-like propagation?

scientific article published on 19 December 2017

List of works by Simon Dujardin

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons

Different tau species lead to heterogeneous tau pathology propagation and misfolding

Ectosomes: a new mechanism for non-exosomal secretion of tau protein

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

Invited review: Animal models of tauopathies and their implications for research/translation into the clinic

Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain

Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease

Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo.

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease

Tau protein liquid-liquid phase separation can initiate tau aggregation

Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo

Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies

What is the evidence that tau pathology spreads through prion-like propagation?